Alexandra Balcom sold $3.5M of Nuvalent (NUVL)

Executed Oct 13 2025, disclosed Oct 15 2025, 2 days later.

Value, as filed

$3.5M

39,800 sh across 6 lots

Executed

Oct 13 2025

the trade date, as filed

Disclosed

Oct 15 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Alexandra Balcom Chief Financial Officer profile →

Alexandra Balcom (Chief Financial Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.5M of NUVL (39,800 sh across 6 lots, as filed), executed Oct 13 2025.

The name

NUVL

Nuvalent Inc NUVL · Healthcare · 94 filings in 24 months ticker →

Healthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Alexandra Balcom in NUVL

NUVLSALE Nuvalent Inc $1.4M
11,430 sh × $123.58
Exec Jul 1
Filed Jul 6 · 4:30 PM ET NUVLSALE Nuvalent Inc $900K
9,091 sh across 4 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET NUVLSALE Nuvalent Inc $1.1M
11,306 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET NUVLSALE Nuvalent Inc $1.2M
11,430 sh across 3 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.5M
25,130 sh across 4 lots
Exec Mar 24
Filed Mar 26 · 5:30 PM ET NUVLSALE Nuvalent Inc $584K
6,004 sh across 4 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NUVLSALE Nuvalent Inc $770K
6,984 sh × $110.31
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc $1.9M
19,620 sh across 5 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET